MRAM:NASDAQEverspin Technologies, Inc. Analysis
Data as of 2026-05-29 - not real-time
$27.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Everspin Technologies has just announced a sizable defense contract that has sparked a sharp rally, pushing the stock well above recent support levels and into a bullish price trend. Revenue growth remains modest but positive, and the company’s gross margins are healthy, yet operating results are still loss‑making with weak cash conversion. Technical indicators show a strong upward bias with short‑term moving averages well above longer‑term averages, while the RSI hovers around the midpoint, suggesting limited over‑bought pressure. However, the MACD histogram has turned negative and trading volume is on a downtrend, hinting at possible short‑term weakness.
Valuation metrics are markedly stretched: the price‑to‑earnings multiple dwarfs the industry average and the discounted cash‑flow model implies a fair value far below the current market price. The stock’s beta and recent volatility are exceptionally high, amplifying downside risk despite the “extreme greed” sentiment reading. In this context, the upside appears limited while the downside risk remains pronounced, especially if the recent price surge cannot be sustained.
Valuation metrics are markedly stretched: the price‑to‑earnings multiple dwarfs the industry average and the discounted cash‑flow model implies a fair value far below the current market price. The stock’s beta and recent volatility are exceptionally high, amplifying downside risk despite the “extreme greed” sentiment reading. In this context, the upside appears limited while the downside risk remains pronounced, especially if the recent price surge cannot be sustained.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Recent price rally may be exhausted
- Negative MACD histogram
- Decreasing volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Defense contract provides multi‑year revenue visibility
- Fundamentals still weak with negative cash flow
- Valuation remains far above fair value
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for niche market leadership in MRAM technology
- High beta and volatility could magnify losses
- Lack of dividend and limited earnings growth
Key Metrics & Analysis
Financial Health
Revenue Growth13.20%
Profit Margin0.50%
P/E Ratio2700.0
ROE0.43%
ROA-5.58%
Debt/Equity4.27
P/B Ratio9.0
Op. Cash Flow$9.1M
Free Cash Flow$-8331500
Industry P/E41.6
Technical Analysis
TrendBullish
RSI49.9
Support$17.48
Resistance$51.50
MA 20$30.70
MA 50$18.89
MA 200$11.92
MACDBearish
VolumeDecreasing
Fear & Greed Index93.8
Valuation
Fair Value$7.81
Target Price$18.00
Upside/Downside-33.33%
GradeOvervalued
TypeBlend
Risk Assessment
Beta3.53
Volatility200.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.